Caribou Biosciences announced on May 16, 2016 the completion of a $30-million Series B financing round. According to a press announcement , the financing included the participation of new investors, including Anterra Capital, Heritage Group, Maverick Capital Ventures, and Pontifax AgTech. F-POriginal Article
You may also like
FDA Approves SpringWorks Therapeutics Treatment for...
ADVANCEMENTS IN GLP-1 ANALOG FORMULATION DEVELOPMENT:...
Axplora Announces €50 Million Investment in GLP-1...
Drug Digest: Advances in Small-Molecule Manufacturing
Navigating Drug Development: The Critical Role of...
MMS Acquires Exploristics and Its Flagship Modeling...
About the author
David Miller
a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.